139 related articles for article (PubMed ID: 38081200)
61. CT-Based Radiomics Analysis Before Thermal Ablation to Predict Local Tumor Progression for Colorectal Liver Metastases.
Taghavi M; Staal F; Gomez Munoz F; Imani F; Meek DB; Simões R; Klompenhouwer LG; van der Heide UA; Beets-Tan RGH; Maas M
Cardiovasc Intervent Radiol; 2021 Jun; 44(6):913-920. PubMed ID: 33506278
[TBL] [Abstract][Full Text] [Related]
62. [Detection of liver metastases in colorectal cancer on chemotherapy. Comparative study between MRI with teslascan and computed tomography with intravenous contrast media].
Beziat C; Pilleul F; Yzebe D; Lombard-Bohas C; Mercier C; Valette PJ
J Radiol; 2004 Mar; 85(3):307-11. PubMed ID: 15192523
[TBL] [Abstract][Full Text] [Related]
63. Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference.
Berger-Kulemann V; Schima W; Baroud S; Koelblinger C; Kaczirek K; Gruenberger T; Schindl M; Maresch J; Weber M; Ba-Ssalamah A
Eur J Surg Oncol; 2012 Aug; 38(8):670-6. PubMed ID: 22652037
[TBL] [Abstract][Full Text] [Related]
64. A prospective comparative study of contrast-enhanced CT, contrast-enhanced MRI and 18F-FDG PET/CT in the preoperative staging of colorectal cancer patients.
Guney IB; Teke Z; Kucuker KA; Yalav O
Ann Ital Chir; 2020; 91():658-667. PubMed ID: 32213686
[TBL] [Abstract][Full Text] [Related]
65. Diagnostic Performance of Contrast Enhanced CT Alone or in Combination with (Non-)Enhanced MRI for Colorectal Liver Metastasis.
Qiu QS; Zhu K; Wang JH; Chen XS; Wang WT; Dong SY; Sun W; Rao SX
Acad Radiol; 2023 Sep; 30(9):1856-1865. PubMed ID: 36481127
[TBL] [Abstract][Full Text] [Related]
66. Improving preoperative detection of synchronous liver metastases in pancreatic cancer with combined contrast-enhanced and diffusion-weighted MRI.
Riviere DM; van Geenen EJM; van der Kolk BM; Nagtegaal ID; Radema SA; van Laarhoven CJHM; Hermans JJ
Abdom Radiol (NY); 2019 May; 44(5):1756-1765. PubMed ID: 30659309
[TBL] [Abstract][Full Text] [Related]
67. [Ultrasound guided ablation therapy of hepatic colorectal metastases: initial experience of real time virtual sonography navigation system].
Yuan CH; Xiu DR; Ge HY; Tan S; Wang HY; Zhang L; Zhang TL
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):956-9. PubMed ID: 24343081
[TBL] [Abstract][Full Text] [Related]
68. Comparison of international guidelines for diagnosis of hepatocellular carcinoma and implications for transplant allocation in liver transplantation candidates with gadoxetic acid enhanced liver MRI versus contrast enhanced CT: a prospective study with liver explant histopathological correlation.
Odedra D; Jandaghi AB; Bhayana R; Elbanna KY; Espin-Garcia O; Fischer SE; Ghanekar A; Sapisochin G; Jhaveri KS
Cancer Imaging; 2022 Oct; 22(1):55. PubMed ID: 36195953
[TBL] [Abstract][Full Text] [Related]
69. Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases.
Koh DM; Collins DJ; Wallace T; Chau I; Riddell AM
Br J Radiol; 2012 Jul; 85(1015):980-9. PubMed ID: 22167501
[TBL] [Abstract][Full Text] [Related]
70. Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation - A cost-effectiveness analysis.
Schnitzer ML; Buchner J; Biechele G; Grawe F; Ingenerf M; von Münchhausen N; Kaiser CG; Kunz WG; Froelich MF; Schmid-Tannwald C; Rübenthaler J
Eur J Radiol; 2023 Jun; 163():110803. PubMed ID: 37004464
[TBL] [Abstract][Full Text] [Related]
71. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
[TBL] [Abstract][Full Text] [Related]
72. Health economic evaluation of ferucarbotran-enhanced MRI in the diagnosis of liver metastases in colorectal cancer patients.
Annemans L; Lencioni R; Warie H; Bartolozzi C; Ciceri M; Müller U
Int J Colorectal Dis; 2008 Jan; 23(1):77-83. PubMed ID: 17912536
[TBL] [Abstract][Full Text] [Related]
73. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.
Motosugi U; Ichikawa T; Morisaka H; Sou H; Muhi A; Kimura K; Sano K; Araki T
Radiology; 2011 Aug; 260(2):446-53. PubMed ID: 21693662
[TBL] [Abstract][Full Text] [Related]
74. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
[TBL] [Abstract][Full Text] [Related]
75. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
[TBL] [Abstract][Full Text] [Related]
76. A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases.
Vilgrain V; Esvan M; Ronot M; Caumont-Prim A; Aubé C; Chatellier G
Eur Radiol; 2016 Dec; 26(12):4595-4615. PubMed ID: 26883327
[TBL] [Abstract][Full Text] [Related]
77. Magnetic Resonance Imaging for Colorectal Cancer Metastasis to the Liver: Comparative Effectiveness Research for the Choice of Contrast Agents.
Seo N; Park MS; Han K; Lee KH; Park SH; Choi GH; Choi JY; Chung YE; Kim MJ
Cancer Res Treat; 2018 Jan; 50(1):60-70. PubMed ID: 28292007
[TBL] [Abstract][Full Text] [Related]
78. Diagnosis of colorectal hepatic metastases: Contrast-enhanced ultrasonography versus contrast-enhanced computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging with diffusion-weighted imaging.
Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Kitamura T; Faima Z; Fukushima K; Araki T; Iino H; Mori Y; Fujii H
J Magn Reson Imaging; 2010 Nov; 32(5):1132-40. PubMed ID: 21031519
[TBL] [Abstract][Full Text] [Related]
79. Small (Kim KW; Kim AY; Kim TK; Park SH; Kim HJ; Lee YK; Park MS; Ha HK; Kim PN; Kim JC; Lee MG
AJR Am J Roentgenol; 2004 May; 182(5):1233-40. PubMed ID: 15100125
[TBL] [Abstract][Full Text] [Related]
80. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
Pech M; Mohnike K; Wieners G; Bialek E; Dudeck O; Seidensticker M; Peters N; Wust P; Gademann G; Ricke J
Strahlenther Onkol; 2008 May; 184(5):256-61. PubMed ID: 18427756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
